Institute of Clinical Medicine - News

The altered metabolites play a role in inflammation, which is also recognized as a possible mechanism of trauma.

New drugs are constantly being developed for breast cancer. In the future, artificial intelligence will be used to assess individual risk for cancer. Liquid biopsy, on the other hand, reveals the risk of cancer recurrence.

First-in-human clinical trials have been initiated at Kuopio University Hospital with a device that assists in the identification of cancerous tissue during surgery.

The PhD study applied a metabolomics approach to examine the metabolic changes in individuals on simvastatin therapy.

The methods developed in the PhD study serve as the basis for further development of near real-time brain tissue classification systems.

Fewer cases of melanoma were observed in people with a history of atopic diseases, such as allergic asthma or rhinitis, than in nonatopic people.

The awarded abstract sums up the link between "Life’s Essential 8" lifestyle and risk factors and the risk of stroke in Finnish men.

The invited speakers are top-notch professionals from the U.S., Canada, Ghana and Finland.

Significant physiologic decrease in insulin resistance during mid-adolescence may stop and reverse arterial stiffness progression, a new study shows.

The UEF opened fall 2022 an internal call for Proof of Concept (PoC) funding to accelerate the commercialization of ideas emerging from research.